CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- 4 Open-market sale 10% owner sold 44,722 shares at an average $20.51 ($917,111)
- 4 Open-market sale 10% owner sold 44,722 shares at an average $20.51 ($917,111)
- 4 Planned sale Chief Financial Officer sold 6,000 shares at an average $19.99 ($119,948)
- 4 Planned sale President, Research & Develop. sold 15,891 shares at an average $20.18 ($320,620)
- 4 Planned sale President, Research & Develop. sold 4,109 shares at an average $20.03 ($82,300)
- 4 Planned sale Chief Financial Officer sold 8,637 shares at $19.98 ($172,562)
- 4 Planned sale President, Research & Develop. sold 18,219 shares at an average $18.62 ($339,281)
- 4 Planned sale President, Research & Develop. sold 600 shares at $18.00 ($10,800)
- 4 Planned sale President & COO sold 847 shares at $16.00 ($13,552)
- 4 Planned sale Chief Financial Officer sold 3,195 shares at $14.97 ($47,832)
- 4 Planned sale President & COO sold 2,303 shares at an average $15.09 ($34,753)
- 4 Planned sale Chief Scientific Officer sold 3,242 shares at an average $15.12 ($49,004)
- 4 Shares withheld for taxes CEO gave up 8,722 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 1,808 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,756 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,731 shares (to pay taxes)
- 4 Planned sale President & COO sold 27,097 shares at an average $16.27 ($440,801)
- 4 Planned sale Chief Scientific Officer sold 1,238 shares at $18.00 ($22,284)
- 4 Planned sale CEO sold 1,900 shares at an average $17.84 ($33,897)
- 4 Planned sale Chief Financial Officer sold 1,758 shares at $14.95 ($26,282)
Page 4 of 13 · 242 filings